Cluster of Excellence ImmunoPreCept

Together with Charité, the Max Delbrück Center for Molecular Medicine (MDC), Humboldt University, Freie Universität Berlin and other partners the DRFZ is researching the transition from health to disease – with the aim to launch a new era of cell-based prevention and early medical intervention in the Berlin Cluster of Excellence ImmunoPreCept (Exploring the Health-Disease Bifurcation for Cell-based Molecular Prevention and Interceptive Medicine).

With decades of successful research in inflammatory systemic diseases, the DRFZ contributes its expertise in functional immune analysis and translational research to the cluster, particularly at the interface between basic research, clinical application and individual prevention.